PacificHealth Laboratories, Inc. (OTCBB: PHLI), a nutrition technology company, announced today that it has signed a consulting agreement with Signal Nutrition LLC, a research and development company headed by former PHLI CEO and founder Dr. Robert Portman. This agreement supports PHLI’S efforts in focusing on its core businesses to drive growth and profitability.

Fred Duffner, President of PacificHealth Laboratories said, “Robert brings a wealth of knowledge and experience in assisting PHLI address its core needs in the area of science and the development of new products. The company has not provided new innovation under its sports nutrition umbrella in over 3 years. There is new science in the category that we need to stay ahead of to insure we continue to bring leadership to the category. We look forward to working with Robert over the next several months to prepare for 2011 and the anticipated growth opportunities.”

The agreement is for 6 months with an option to renew for an additional 6 months. For further information please refer to the 8K filed with the SEC on July 29, 2010.

About the Company:

PacificHealth Laboratories, Inc. (PHLI.OB), a leading nutrition technology company, has been a pioneer in discovering, developing and commercializing patented, protein-based nutritional products that stimulate specific peptides involved in appetite regulation and that activate biochemical pathways involved in muscle performance and growth. PHLI’s principle areas of focus include weight loss, management of Type 2 diabetes and sports performance. To learn more, visit www.pacifichealthlabs.com.

Notice: This news release and oral statements made from time to time by Company representatives concerning the same subject matter may contain so-called "forward-looking statements". These statements can be identified by introductory words such as "expects", "plans", "will", "estimates", "forecasts", "projects" or words of similar meaning and by the fact they do not relate strictly to historical or current facts. Forward-looking statements frequently are used in discussing new products and their potential. Many factors may cause actual results to differ from forward-looking statements, including inaccurate assumptions and a broad variety of risks and uncertainties, some of which are known, such general economic conditions, consumer product acceptance and competitive products, and others of which are not. No forward-looking statements are a guarantee of future results or events, and one should avoid placing undue reliance on such statements.

PacificHealth Laboratories (CE) (USOTC:PHLI)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 PacificHealth Laboratories (CE) 차트를 더 보려면 여기를 클릭.
PacificHealth Laboratories (CE) (USOTC:PHLI)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 PacificHealth Laboratories (CE) 차트를 더 보려면 여기를 클릭.